|
π
|
Effect of interleukin-1Ξ² inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
114 auth.
P. Ridker,
Jean G Macfadyen,
T. Thuren,
Brendan M. Everett,
P. Libby,
R. Glynn,
P. Ridker,
A. Lorenzatti,
H. Krum,
J. Varigos,
P. Siostrzonek,
P. Sinnaeve,
F. Fonseca,
J. Nicolau,
N. Gotcheva,
...
J. Genest,
Huo Yong,
Miguel Urina-Triana,
D. MiliΔiΔ,
R. CΓfkovΓ‘,
R. Vettus,
W. Koenig,
S. Anker,
A. Manolis,
F. Wyss,
T. Forster,
A. Sigurdsson,
Prem Pais,
A. Fucili,
H. Ogawa,
H. Shimokawa,
I. Veze,
B. Petrauskiene,
Leon Salvador,
J. Kastelein,
J. Cornel,
T. Klemsdal,
F. Medina,
A. Budaj,
L. Vida-Simiti,
Z. Kobalava,
P. Otasevic,
D. Pella,
M. LainΕ‘Δak,
K. Seung,
P. Commerford,
M. Dellborg,
M. Donath,
Juey-Jen Hwang,
H. Kultursay,
M. Flather,
C. Ballantyne,
S. Bilazarian,
William Chang,
C. East,
Brendan M. Everett,
L. Forgosh,
Robert Glynn,
Barry Harris,
M. Ligueros,
Erin Bohula,
Bindu Charmarthi,
Susan Cheng,
S. Chou,
J. Danik,
G. McMahon,
B. Maron,
M. Ning,
B. Olenchock,
Reena L. Pande,
T. Perlstein,
A. Pradhan,
N. Rost,
A. Singhal,
V. Taqueti,
N. Wei,
H. Burris,
A. Cioffi,
A. Dalseg,
N. Ghosh,
J. Gralow,
T. Mayer,
H. Rugo,
V. Fowler,
A. Limaye,
S. Cosgrove,
D. Levine,
Renato Lopes,
J. Scott,
R. Hilkert,
Georgia Tamesby,
C. Mickel,
B. Manning,
Julian Woelcke,
M. Tan,
S. Manfreda,
Tom Ponce,
J. Kam,
R. Saini,
Kehur Banker,
T. Salko,
Panjat Nandy,
Ronda Tawfik,
Greg O'Neil,
S. Manne,
Pravin Jirvankar,
S. Lal,
Deepak Nema,
Jaison Jose,
R. Collins,
K. Bailey,
R. Blumenthal,
H. Colhoun,
B. Gersh
|
9 |
2017 |
9
π
|
